Skip to main content
Contact Us
Subscribe
E-Edition
80°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Precision BioSciences, Inc. - Common Stock
(NQ:
DTIL
)
4.590
+0.070 (+1.55%)
Streaming Delayed Price
Updated: 11:01 AM EDT, Jul 9, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Precision BioSciences, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Preview: Precision BioSciences's Earnings
March 08, 2023
Via
Benzinga
Precision BioSciences to Report Fourth Quarter and Fiscal Year 2022 Results on March 9, 2023
March 02, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Announces Senior Leadership Promotions and Organizational Changes
February 24, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences to Participate in Upcoming H.C. Wainwright Cell Therapy Virtual Conference
February 22, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Earnings Perspective: Return On Capital Employed
December 06, 2022
Via
Benzinga
There's a Lot of Upside For Emerging Gene-Editing Companies
February 21, 2023
These four gene-editing companies are brand new, with very high upside potential. The industry itself is still emerging, which means more growth could come.
Via
MarketBeat
Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
February 14, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
February 06, 2023
Via
Benzinga
Precision BioSciences Recaps 2022 Accomplishments and Outlines 2023 Corporate Priorities and Planned Portfolio Milestones
January 09, 2023
From
Precision BioSciences
Via
Business Wire
Precision BioSciences Receives Favorable Type C Feedback from the FDA on the Company’s Chemistry, Manufacturing, and Controls (CMC) Strategies for Late-Stage Development of Azercabtagene Zapreleucel, its Lead Allogeneic CAR T Clinical Candidate
January 06, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Presents Analysis of Azer-Cel, Allogeneic CAR T Product Attributes Related to In Vivo Pharmacokinetics, Pharmacodynamics, and Clinical Outcomes at 2022 American Society of Hematology Annual Meeting
December 10, 2022
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Announces Change to its Board of Directors
November 10, 2022
From
Precision BioSciences, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Friday
December 23, 2022
OnFriday, 143 stocks hit new 52-week lows.
Via
Benzinga
Coinbase To $80? Plus Deutsche Bank Cuts PT On This Stock By 80%
November 10, 2022
Citigroup cut the price target on Coinbase Global, Inc. (NASDAQ: COIN) from $105 to $80. Citigroup analyst Peter Christiansen maintained a Buy rating on the stock. Coinbase shares rose 2.1% to $46.95...
Via
Benzinga
Precision BioSciences Reports Third Quarter 2022 Financial Results and Provides Business Update
November 08, 2022
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences's Earnings Outlook
November 07, 2022
Precision BioSciences (NASDAQ:DTIL) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
November 04, 2022
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Announces Data Presentation on Effective Cell Dose and Functional Attributes of CD19 Allogeneic CAR T, Azer-Cel, at the Upcoming 2022 American Society of Hematology (ASH) Annual Meeting
November 03, 2022
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences to Report Third Quarter 2022 Financial Results on November 8, 2022
November 02, 2022
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Announces Grant of Inducement Award Pursuant to Nasdaq Listing Rule 5635(c)(4)
October 26, 2022
From
Precision BioSciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 18, 2022
Gainers
Via
Benzinga
Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 29th Congress
October 11, 2022
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences to Participate in Upcoming Jefferies Cell & Genetic Medicine Summit
September 22, 2022
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences to Participate in Upcoming H.C. Wainwright 24th Annual Global Investment Conference
September 07, 2022
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Announces Senior Leadership Organizational Changes
September 02, 2022
From
Precision BioSciences, Inc.
Via
Business Wire
Looking Into Precision BioSciences, Inc. - Common Stock's Return On Capital Employed
August 30, 2022
Benzinga Pro data, Precision BioSciences, Inc. - Common Stock (NASDAQ:DTIL) reported Q2 sales of $3.82 million. Earnings fell to a loss of $31.04 million, resulting in a 10.18% decrease from last...
Via
Benzinga
Precision BioSciences: Q2 Earnings Insights
August 08, 2022
Precision BioSciences (NASDAQ:DTIL) reported its Q2 earnings results on Monday, August 8, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Precision BioSciences Reports Second Quarter 2022 Financial Results and Provides Business Update
August 08, 2022
From
Precision BioSciences, Inc.
Via
Business Wire
Earnings Preview: Precision BioSciences, Inc. - Common Stock
August 05, 2022
Precision BioSciences, Inc. - Common Stock (NASDAQ:DTIL) is set to give its latest quarterly earnings report on Monday, 2022-08-08. Here's what investors need to know before the announcement.
Via
Benzinga
Precision BioSciences to Report Second Quarter 2022 Financial Results on August 8, 2022
August 01, 2022
From
Precision BioSciences, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.